The Oral Histone Deacetylase Inhibitor LBH589 Is a...

The Oral Histone Deacetylase Inhibitor LBH589 Is a Potential and Promising Therapeutic Agent in Multiple Myeloma after at Least Two Lines of Chemotherapy Including Bortezomib or Lenalidomide

Schmitt, Stefan, Ho, Anthony D., Goldschmidt, Hartmut
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Year:
2010
Journal:
Onkologie
DOI:
10.1159/000286447
File:
PDF, 597 KB
2010
Conversion to is in progress
Conversion to is failed